Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: buffalodon2003	8/12/2009 10:12:02 PM
	of 370

We're back - Vion has risen from ashes. Stock rose 32% today to $3.75 (up .91) after being down near .40/share. Oncologic Drugs Advisory Committee Meeting scheduled 9/1/09 for lead and basically only drug, Onrigin (formerly Cloretazine). Is there anyone left out there from old group. I do understand the sting from the reverse split, but company had one drug and they had to nail the application (standard review).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext